A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Neonc Technologies, Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
Jazz Pharmaceuticals
AstraZeneca
Eli Lilly and Company
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Amgen
SystImmune Inc.
xCures
Daiichi Sankyo
Takeda
Eli Lilly and Company
Adela, Inc
Perspective Therapeutics
Second Life Therapeutics
Novartis
Var2 Pharmaceuticals
VM Oncology, LLC
Tanabe Pharma America, Inc.
Pfizer
NeoTX Therapeutics Ltd.
Stella Pharma Corporation
Astellas Pharma Inc
Tempus AI
AbbVie
Immunitas Therapeutics
Actym Therapeutics, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Travera Inc
Pfizer
Arcus Biosciences, Inc.
Guardant Health, Inc.
Paradigm Health
Novita Pharmaceuticals, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Ascentage Pharma Group Inc.
NGM Biopharmaceuticals, Inc
Tempus AI
Janssen Research & Development, LLC
Revolution Medicines, Inc.
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
Singlera Genomics Inc.
Seagen Inc.
Immatics US, Inc.
Zymeworks BC Inc.